Related Experiment Video
Updated: Oct 14, 2025

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound
Published on: December 2, 2014
Large Artery Stiffness: A Companion to the 2015 AHA Science Statement on Arterial Stiffness
Jimena Rey-García1,2, Raymond R Townsend3
1Department of Preventive Medicine and Public Health, Universidad Autónoma de Madrid, Madrid, Spain.
Insights
Large artery stiffness (LAS) is a key cardiovascular risk factor. Guidelines vary on assessing LAS using pulse wave velocity (PWV), but it aids risk prediction and may be improved by certain treatments.
Area of Science:
- Cardiology
- Vascular Medicine
- Hypertension Research
Background:
- Large artery stiffness (LAS) is an independent predictor of cardiovascular disease and mortality.
- Current hypertension guidelines present differing recommendations on the routine assessment of LAS.
- Pulse wave velocity (PWV) is recognized as a marker of target organ damage, though its systematic use is debated globally.
Purpose of the Study:
- To provide an updated review of large artery stiffness (LAS).
- To discuss the varying guideline positions on assessing LAS via pulse wave velocity (PWV).
- To summarize recent advances in treatments impacting LAS.
Main Methods:
- Literature review of current guidelines and recent studies on LAS.
- Analysis of the role of pulse wave velocity (PWV) in cardiovascular risk stratification.
- Evaluation of therapeutic interventions affecting LAS, including dietary, pharmacological, and procedural approaches.
Main Results:
- Guideline recommendations for assessing LAS using PWV differ significantly between European, Asian, and North American authorities.
- PWV demonstrates value in predicting cardiovascular events and refining risk classification, particularly in intermediate-risk individuals.
- Interventions like sodium restriction, exercise, statins, mineralocorticoid blockers, and renal denervation show varied effects on LAS.
Conclusions:
- Despite guideline discrepancies, PWV is a valuable tool for cardiovascular risk assessment.
- Therapeutic strategies targeting LAS show promise, with ongoing research into their efficacy.
- Further research is needed to standardize LAS assessment and optimize treatment strategies.
Abstract:
Large artery stiffness (LAS) has proven to be an independent risk factor for cardiovascular disease and mortality. Nevertheless, the position of current hypertension guidelines regarding the usefulness of assessing LAS differs across different continents. In general, European Guidelines recognize pulse wave velocity (PWV) as a marker of target organ damage but do not recommend its systematic use in general population. Asian guidelines consider PWV as a recommended test at diagnosis of hypertension, in contrast to North American guidelines that do not state any position about its usefulness. However, PWV predicts cardiovascular events, and several studies have shown that it improves risk classification adjusting for established risk factors especially for intermediate-risk patients. Finally, some advances have been made related to treatments affecting LAS. Dietary interventions such as sodium restriction and exercise-based interventions have a modest effect in reducing LAS. Pharmacological interventions, such as statins, or more recent advances with mineralocorticoid blocker seem to have a beneficial effect. Last, controversial effects of renal denervation on LAS have been found. Our goal here is to update the reader on LAS on these areas since the 2015 American Heart Association Scientific Statement.
Related Concept Videos
Peripheral Artery Disease I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis I: Introduction
Atherosclerosis IV: Nursing Management
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Atherosclerosis III: Management

